Second Sight Medical Products Inc (EYES)

[AugustStockInformer]

Great new interview with the CEO of EYES:

https://www.twst.com/interview/interview-with-the-president-and-ceo-second-sight-medical-products-inc-nasdaqeyes

the Argus II treats patients with severe to profound blindness due to retinitis pigmentosa, otherwise known as RP, which is a hereditary disease that basically causes the photoreceptor cells on the outermost layer of the retina to degenerate or to die over time. An individual will usually get diagnosed with this in their teens or 20s, and it varies, but over the next eight, 10, 15 or 20 years, they lose more and more vision every day and eventually experience total blindness.

What our technology does is stimulate the retina through an implanted array that has 60 electrodes, which can be thought of as 60 spots of light. This array takes the place of the photoreceptors that have died over time and stimulates the eye. The remaining cells of the eye pick up this stimulation, see it as light and then transfer that via the optic nerve to the brain, which interprets this as vision.

The Argus system includes a pair of glasses, which have an external miniature camera connected to a video processing unit, or VPU, which processes the video image that’s captured by the camera. The VPU converts it to a set of instructions. Those instructions travel via wire back up to a transmitter on the glasses. The transmitter then sends both power and the instructions wirelessly to the array. The array, as I said earlier, then stimulates the eye and creates the artificial vision.